Abeona Therapeutics Historical PE Ratio image   This ABEO PE ratio history page last updated 3/22/2024
Abeona Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/18/2024
6.99-0.64-2.56NA
Q3 2023
11/13/2023
4.50-0.48-1.92NA
Q2 2023
8/8/2023
2.98-0.92-3.68NA
Q1 2023
5/11/2023
2.97-0.54-2.16NA
Q4 2022
3/29/2023
2.811.526.080.5
Q3 2022
11/14/2022
4.15-1.48-5.92NA
Q2 2022
8/11/2022
4.66-2.08-8.32NA
Q1 2022
5/13/2022
4.00-2.50-10.00NA
Q4 2021
3/31/2022
8.00-3.50-14.00NA
Q3 2021
11/15/2021
22.75-4.00-16.00NA
Q2 2021
7/28/2021
32.00-4.00-16.00NA
Q1 2021
5/18/2021
39.00-4.25-17.00NA
Q4 2020
3/24/2021
44.50-4.25-17.00NA
Q3 2020
11/9/2020
26.75-2.00-8.00NA
Q2 2020
8/10/2020
74.75-3.50-14.00NA
Q1 2020
5/6/2020
60.75-13.00-52.00NA
Q4 2019
3/16/2020
36.25-7.50-30.00NA
Q3 2019
11/12/2019
57.25-8.75-35.00NA
Q2 2019
8/9/2019
57.25-12.25-49.00NA
Q1 2019
5/11/2019
NA-9.75-39.00NA
Q4 2018
3/18/2019
202.25-9.00-36.00NA
Q3 2018
11/9/2018
234.00-8.50-34.00NA
Q2 2018
8/9/2018
363.75-6.25-25.00NA
Q1 2018
5/11/2018
491.25-4.50-18.00NA
Q4 2017
3/27/2018
350.00-4.75-19.00NA
Q3 2017
11/15/2017
418.75-3.25-13.00NA
Q2 2017
8/15/2017
202.50-5.25-21.00NA
Q1 2017
5/15/2017
155.00-3.25-13.00NA
Q4 2016
3/31/2017
125.00-4.75-19.00NA
Q3 2016
11/10/2016
150.00-2.00-8.00NA
Q2 2016
8/16/2016
98.25-5.00-20.00NA
Q1 2016
5/17/2016
60.50-4.25-17.00NA
Q4 2015
3/8/2016
65.75-1.75-7.00NA
Q3 2015
11/16/2015
98.50-4.75-19.00NA
Q2 2015
8/14/2015
133.75-4.00-16.00NA
Q1 2015
5/14/2015
208.50-2.50-10.00NA
Abeona Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/18/2024
6.99-0.64-2.58NA
Q3 2023
11/13/2023
4.50-0.48-0.42NA
Q2 2023
8/8/2023
2.98-0.92-1.42NA
Q1 2023
5/11/2023
2.97-0.54-2.58NA
Q4 2022
3/29/2023
2.811.52-4.54NA
Q3 2022
11/14/2022
4.15-1.48-9.56NA
Q2 2022
8/11/2022
4.66-2.08-12.08NA
Q1 2022
5/13/2022
4.00-2.50-14.00NA
Q4 2021
3/31/2022
8.00-3.50-15.75NA
Q3 2021
11/15/2021
22.75-4.00-16.50NA
Q2 2021
7/28/2021
32.00-4.00-14.50NA
Q1 2021
5/18/2021
39.00-4.25-14.00NA
Q4 2020
3/24/2021
44.50-4.25-22.75NA
Q3 2020
11/9/2020
26.75-2.00-26.00NA
Q2 2020
8/10/2020
74.75-3.50-32.75NA
Q1 2020
5/6/2020
60.75-13.00-41.50NA
Q4 2019
3/16/2020
36.25-7.50-38.25NA
Q3 2019
11/12/2019
57.25-8.75-39.75NA
Q2 2019
8/9/2019
57.25-12.25-39.50NA
Q1 2019
5/11/2019
NA-9.75-33.50NA
Q4 2018
3/18/2019
202.25-9.00-28.25NA
Q3 2018
11/9/2018
234.00-8.50-24.00NA
Q2 2018
8/9/2018
363.75-6.25-18.75NA
Q1 2018
5/11/2018
491.25-4.50-17.75NA
Q4 2017
3/27/2018
350.00-4.75-16.50NA
Q3 2017
11/15/2017
418.75-3.25-16.50NA
Q2 2017
8/15/2017
202.50-5.25-15.25NA
Q1 2017
5/15/2017
155.00-3.25-15.00NA
Q4 2016
3/31/2017
125.00-4.75-16.00NA
Q3 2016
11/10/2016
150.00-2.00-13.00NA
Q2 2016
8/16/2016
98.25-5.00-15.75NA
Q1 2016
5/17/2016
60.50-4.25-14.75NA
Q4 2015
3/8/2016
65.75-1.75-13.00NA
Q3 2015
11/16/2015
98.50-4.75NANA
Q2 2015
8/14/2015
133.75-4.00NANA
Q1 2015
5/14/2015
208.50-2.50NANA
Quotes delayed 20 minutes

Email EnvelopeFree ABEO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Abeona Therapeutics (ABEO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ABIO PE Ratio History
ABMD PE Ratio History
ABOS PE Ratio History
ABSI PE Ratio History
ABT PE Ratio History
ABVC PE Ratio History
ACAD PE Ratio History
ACCD PE Ratio History
ACER PE Ratio History
ACET PE Ratio History
How should the ABEO historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Abeona Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ABEO Historical PE Ratio page.

What is the average historical PE for ABEO based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ABEO historical PE ratio using the annualized quarterly earnings method works out to 0.5.

What is the average historical PE for ABEO based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ABEO historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Abeona Therapeutics Historical PE Ratio information for Abeona Therapeutics' stock. The average ABEO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 0.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ABEO historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ABEO historical PE result, against the recent PE: when this page was posted on 3/21/2024, the most recent closing price for ABEO had been 7.53, and the most recent quarterly earnings result, annualized, was 6.08. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent ABEO PE on 3/21/2024 based on annualized quarterly EPS was 1.2. Based on ABEO's history, that recent PE is elevated relative to the historical average, with the recent PE 140.0% higher than the historical average PE across our data set for Abeona Therapeutics.

For self directed investors doing their due diligence on ABEO or any other given stock, valuation analysis for ABEO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Abeona Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ABEO. Thanks for visiting, and the next time you need to research ABEO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: L Price Target, TRB Historical Stock Prices, LIWA Videos.

 

Abeona Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.